Antiretrovirals and Risk of COVID-19 Diagnosis and Hospitalization in HIV-Positive Persons

del Amo, Julia; Polo, Rosa; Moreno, Santiago; Díaz, Asunción; Martínez, Esteban; Arribas, José Ramón; Jarrín, Inma; Hernán, Miguel A.
Thumbnail
Estadísticas
Estadísticas
Identificadores
Identificadores
Registro completo
Servicios
Servicios
RISMendeleyLinksolver
Visualización o descarga de ficheros
Visualización o descarga de ficheros
Autor corporativo
The Spanish HIV/COVID-19 Collaboration
Fecha de publicación
2020
Título de revista
Epidemiology
Tipo de contenido
Artigo
DeCS
VIH | incidencia | conducta cooperativa | riesgo | inhibidores de la integrasa
MeSH
Risk | Integrase Inhibitors | Cooperative Behavior | HIV | Incidence
Resumen
The risk of COVID-19 diagnosis and hospitalization among HIV-positive individuals is lower in those receiving treatment with TDF/FTC than in those receiving other ART regimes. This association does not seem to be explained by confounding due to unmeasured clinical characteristics. Our finding is compatible with accumulating evidence on a potential effect of TDF/FTC against SARS-CoV-2 infection.